Trial Profile
A Comparison of Prandial Insulin Lispro Mixtures Therapy to Glargine Basal-Bolus Therapy With Insulin Lispro on the Overall Glycemic Control of Patients With Type 2 Diabetes Previously Treated With Oral Agents Combined With Insulin Glargine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary) ; Insulin glargine; Insulin neutral protamine lispro/insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 01 Aug 2017 Results of a post-hoc analysis comparing prandial premixed therapy (PPT) to basal-bolus therapy (BBT) in type-2 diabetes mellitus patients, published in the Diabetes Therapy.
- 01 Aug 2017 Post hoc ananlysis results comparing Premixed and Basal-Bolus Insulin regimens published in the Diabetes Therapy
- 05 Dec 2005 New trial record.